A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL
Published Online: 2011-07-20
Journal: Investigational New Drugs•Publisher: Springer Science and Business Media LLC
Authors: Choung-Soo Kim•In Gab Jeong•Je-Hwan Lee•Jene Choi•Jung Jin Hwang•Mi Joung Kim•Sejin Jang•Seonggu Ro•Taelim Kim•Yong Sook Kim
